Newsfeeds - Spark Newswire

4 minute read

The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts

Today, 3:46 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10)

ALKS

1 minute read

Eli Lilly-Innovent Biologics Score Expanded Use Approval of Tyvyt n Lung Cancer Patients In China

By Vandana Singh

Today, 3:46 AM

The National Medical Products Administration (NMPA) of China has approved Innovent Biologics Inc (OTC:IVBXF) and Eli Lilly And Co’s (NYSE:LLY) Tyvyt (sintilimab injection)…

IVBIY

2 minute read

News

Lilly Reveals Critical Barriers to Optimal Migraine Care and Insights From Novel Clinical and Patient-Centric Real-World Evidence, Supporting Lilly’s Preventive and Acute Treatment Portfolio at AHS 2021

By Benzinga Newsdesk

Today, 3:46 AM

To improve the understanding and advance the treatment of migraine, Eli Lilly and Company (NYSE: LLY) presented data on unmet needs in migraine from the OVERCOME (U.S.) study and on its portfolio of migraine

LLY

1 minute read

Lilly’s Olumiant Found to Lower Pain In Late-Stage Rheumatoid Arthritis Trial

By Vandana Singh

Today, 3:46 AM

Eli Lilly And Co (NYSE:LLY) has reported posthoc analyses data from the Phase 3 RA-BEAM study that showed Olumiant 4mg (baricitinib)…

ABBV

1 minute read

Justice Department Opens Probe In Presumed lapses at Eli Lilly’s COVID-19 Drug Plant: Reuters

By Vandana Singh

Today, 3:46 AM

The U.S. Justice Department has launched a criminal investigation into Eli Lilly and Co (NYSE:LLY) focused on alleged manufacturing irregularities…

EBS

1 minute read

Uncategorized

Eli Lilly Slapped With DoJ Subpoena Over COVID-19 Drug Manufacturing Plant: Reuters

By Vandana Singh

Today, 3:46 AM

Eli Lilly and Co (NYSE:LLY) has received a subpoena from the U.S. Department of Justice related to its New Jersey plant…

LLY

5 minute read

Uncategorized

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal

By Shanthi Rexaline

Today, 3:46 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24)

ADVM

2 minute read

Uncategorized

The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation

By Shanthi Rexaline

Today, 3:46 AM

Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts.

ASND

1 minute read

Uncategorized

Lilly Announces ‘Co.’s tirzepatide achieves all primary and key secondary study outcomes against insulin glargine in adults with type 2 diabetes and increased cardiovascular risk in SURPASS-4 trial’

By Benzinga Newsdesk

Today, 3:46 AM

Tirzepatide led to superior A1C and body weight reductions from baseline across all three doses in adults with type 2 diabetes who have increased cardiovascular (CV) risk compared to titrated insulin glargine in topline

LLY

1 minute read

Uncategorized

Arecor Announced Exclusive Formulation Study Collaboration With Lilly

By Charles Gross

Today, 3:46 AM

Arecor Limited ("Arecor" or "the Company"), the biopharmaceutical company advancing today's therapies to enable healthier lives, today announces that it has signed a formulation study partnership with Eli Lilly and Company (NYSE: LLY).

LLY